foxo4-dri human trial FOXO4-DRI: Status, Cancer Research & Senolytic Data Synedica NAD+ & B12 Size:1000 mcg/ml - 30 ml x 2 Furosemide Injection

foxo4-dri human trial FOXO4-DRI: Status, Cancer Research & Senolytic Data Synedica NAD+ & B12 Size:1000 mcg/ml - 30 ml x 2 Furosemide Injection

Synedica NAD+ & B12 Kit

Common Topical Application Patterns Use case Facial anti-aging (community use) Concentration 1-2% Frequency Once or twice daily Cycle length 8-12 weeks Use case Scalp / hair-research interest Concentration 1-3% Frequency Daily Cycle length 12+ weeks ongoing Use case Compounded post-procedure Concentration 1-2% Frequency Per clinician guidance Cycle length Per clinician guidance Topical concentrations are typically expressed as percent weight

Furosemide Injection

Size:1000 mcg/ml - 30 ml x 2

Effective treatment of cobalamin deficiency with oral cobalamin